Who owns BIOMARIN PHARMACEUTICAL INC (BMRN)? Elite investor 13F holders
9 tracked elite investors reported holding BIOMARIN PHARMACEUTICAL INC as of 2026-06-30, including Dodge & Cox Funds, Viking Global Investors, Oaktree Capital Management, Renaissance Technologies LLC, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
9 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Dodge & Cox Funds | BIOMARIN PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 849426895.00 USD | 14844930.000000 | Shares | add | Original filing |
| Viking Global Investors | BIOMARIN PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 435819735.00 USD | 7616563.000000 | Shares | add | Original filing |
| Oaktree Capital Management | BIOMARIN PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 62373155.00 USD | 64025000.000000 | Principal | add | Original filing |
| Renaissance Technologies LLC | BIOMARIN PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 25856059.00 USD | 451871.000000 | Shares | reduce | Original filing |
| Rubric Capital | BIOMARIN PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| D.E. Shaw | BIOMARIN PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 5276485.00 USD | 92214.000000 | Shares | reduce | Original filing |
| Bridgewater Associates | BIOMARIN PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 15730407.00 USD | 274911.000000 | Shares | add | Original filing |
| Gotham Asset Management | BIOMARIN PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1638838.00 USD | 28641.000000 | Shares | reduce | Original filing |
| Torray Funds | BIOMARIN PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-07-30 00:00:00 | 4446280.00 USD | 77705.000000 | Shares | reduce | Original filing |
| GAMCO | BIOMARIN PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 743860.00 USD | 13000.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.